Peptide-mediated activation of Akt and extracellular regulated kinase signaling prevents lymphocyte apoptosis

Jonathan E. McDunn, Jared T. Muenzer, Latif Rachdi, Katherine C. Chang, Chris G. Davis, W. Michael Dunne, David Piwnica-Worms, Ernesto Bernal Mizrachi, Richard S. Hotchkiss

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Lymphocyte apoptosis is a hallmark of sepsis and contributes to disease mortality. In other acute injuries, such as myocardial and cerebral ischemia/reperfusion, apoptosis plays a significant role in disease-associated morbidity and mortality. We previously showed that constitutive activation of the potent antiapoptotic Akt/protein kinase B signaling pathway in lymphocytes both reduces sepsis-induced lymphocyte apoptosis and confers a significant survival advantage compared to wild-type littermates. Here, we demonstrate a therapeutic approach to acutely augment Akt activity in a wild-type animal. A cell-permeable peptide conjugated to the Akt-binding domain of the endogenous Akt coactivator, Tcl-1, prolongs Akt activity, activates extracellular regulated kinase (ERK) signaling and protects lymphocytes from numerous apoptotic stimuli both in vitro and in vivo. Molecular approaches to activate the antiapoptotic Akt and ERK signaling pathways may provide a novel tool to study these signaling pathways, as well as a new antiapoptotic strategy for the treatment of sepsis and other acute injuries.

Original languageEnglish (US)
Pages (from-to)561-568
Number of pages8
JournalFASEB Journal
Volume22
Issue number2
DOIs
StatePublished - Feb 2008
Externally publishedYes

Fingerprint

Lymphocytes
phosphotransferases (kinases)
Phosphotransferases
lymphocytes
apoptosis
Chemical activation
peptides
Apoptosis
Sepsis
Peptides
Proto-Oncogene Proteins c-akt
Wild Animals
Mortality
Wounds and Injuries
ischemia
Brain Ischemia
protein kinases
Reperfusion
Myocardial Ischemia
morbidity

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

McDunn, J. E., Muenzer, J. T., Rachdi, L., Chang, K. C., Davis, C. G., Dunne, W. M., ... Hotchkiss, R. S. (2008). Peptide-mediated activation of Akt and extracellular regulated kinase signaling prevents lymphocyte apoptosis. FASEB Journal, 22(2), 561-568. https://doi.org/10.1096/fj.07-8283com

Peptide-mediated activation of Akt and extracellular regulated kinase signaling prevents lymphocyte apoptosis. / McDunn, Jonathan E.; Muenzer, Jared T.; Rachdi, Latif; Chang, Katherine C.; Davis, Chris G.; Dunne, W. Michael; Piwnica-Worms, David; Bernal Mizrachi, Ernesto; Hotchkiss, Richard S.

In: FASEB Journal, Vol. 22, No. 2, 02.2008, p. 561-568.

Research output: Contribution to journalArticle

McDunn, JE, Muenzer, JT, Rachdi, L, Chang, KC, Davis, CG, Dunne, WM, Piwnica-Worms, D, Bernal Mizrachi, E & Hotchkiss, RS 2008, 'Peptide-mediated activation of Akt and extracellular regulated kinase signaling prevents lymphocyte apoptosis', FASEB Journal, vol. 22, no. 2, pp. 561-568. https://doi.org/10.1096/fj.07-8283com
McDunn, Jonathan E. ; Muenzer, Jared T. ; Rachdi, Latif ; Chang, Katherine C. ; Davis, Chris G. ; Dunne, W. Michael ; Piwnica-Worms, David ; Bernal Mizrachi, Ernesto ; Hotchkiss, Richard S. / Peptide-mediated activation of Akt and extracellular regulated kinase signaling prevents lymphocyte apoptosis. In: FASEB Journal. 2008 ; Vol. 22, No. 2. pp. 561-568.
@article{26d4a17fd5184eadbda957932b4423dc,
title = "Peptide-mediated activation of Akt and extracellular regulated kinase signaling prevents lymphocyte apoptosis",
abstract = "Lymphocyte apoptosis is a hallmark of sepsis and contributes to disease mortality. In other acute injuries, such as myocardial and cerebral ischemia/reperfusion, apoptosis plays a significant role in disease-associated morbidity and mortality. We previously showed that constitutive activation of the potent antiapoptotic Akt/protein kinase B signaling pathway in lymphocytes both reduces sepsis-induced lymphocyte apoptosis and confers a significant survival advantage compared to wild-type littermates. Here, we demonstrate a therapeutic approach to acutely augment Akt activity in a wild-type animal. A cell-permeable peptide conjugated to the Akt-binding domain of the endogenous Akt coactivator, Tcl-1, prolongs Akt activity, activates extracellular regulated kinase (ERK) signaling and protects lymphocytes from numerous apoptotic stimuli both in vitro and in vivo. Molecular approaches to activate the antiapoptotic Akt and ERK signaling pathways may provide a novel tool to study these signaling pathways, as well as a new antiapoptotic strategy for the treatment of sepsis and other acute injuries.",
author = "McDunn, {Jonathan E.} and Muenzer, {Jared T.} and Latif Rachdi and Chang, {Katherine C.} and Davis, {Chris G.} and Dunne, {W. Michael} and David Piwnica-Worms and {Bernal Mizrachi}, Ernesto and Hotchkiss, {Richard S.}",
year = "2008",
month = "2",
doi = "10.1096/fj.07-8283com",
language = "English (US)",
volume = "22",
pages = "561--568",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "2",

}

TY - JOUR

T1 - Peptide-mediated activation of Akt and extracellular regulated kinase signaling prevents lymphocyte apoptosis

AU - McDunn, Jonathan E.

AU - Muenzer, Jared T.

AU - Rachdi, Latif

AU - Chang, Katherine C.

AU - Davis, Chris G.

AU - Dunne, W. Michael

AU - Piwnica-Worms, David

AU - Bernal Mizrachi, Ernesto

AU - Hotchkiss, Richard S.

PY - 2008/2

Y1 - 2008/2

N2 - Lymphocyte apoptosis is a hallmark of sepsis and contributes to disease mortality. In other acute injuries, such as myocardial and cerebral ischemia/reperfusion, apoptosis plays a significant role in disease-associated morbidity and mortality. We previously showed that constitutive activation of the potent antiapoptotic Akt/protein kinase B signaling pathway in lymphocytes both reduces sepsis-induced lymphocyte apoptosis and confers a significant survival advantage compared to wild-type littermates. Here, we demonstrate a therapeutic approach to acutely augment Akt activity in a wild-type animal. A cell-permeable peptide conjugated to the Akt-binding domain of the endogenous Akt coactivator, Tcl-1, prolongs Akt activity, activates extracellular regulated kinase (ERK) signaling and protects lymphocytes from numerous apoptotic stimuli both in vitro and in vivo. Molecular approaches to activate the antiapoptotic Akt and ERK signaling pathways may provide a novel tool to study these signaling pathways, as well as a new antiapoptotic strategy for the treatment of sepsis and other acute injuries.

AB - Lymphocyte apoptosis is a hallmark of sepsis and contributes to disease mortality. In other acute injuries, such as myocardial and cerebral ischemia/reperfusion, apoptosis plays a significant role in disease-associated morbidity and mortality. We previously showed that constitutive activation of the potent antiapoptotic Akt/protein kinase B signaling pathway in lymphocytes both reduces sepsis-induced lymphocyte apoptosis and confers a significant survival advantage compared to wild-type littermates. Here, we demonstrate a therapeutic approach to acutely augment Akt activity in a wild-type animal. A cell-permeable peptide conjugated to the Akt-binding domain of the endogenous Akt coactivator, Tcl-1, prolongs Akt activity, activates extracellular regulated kinase (ERK) signaling and protects lymphocytes from numerous apoptotic stimuli both in vitro and in vivo. Molecular approaches to activate the antiapoptotic Akt and ERK signaling pathways may provide a novel tool to study these signaling pathways, as well as a new antiapoptotic strategy for the treatment of sepsis and other acute injuries.

UR - http://www.scopus.com/inward/record.url?scp=38949168061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38949168061&partnerID=8YFLogxK

U2 - 10.1096/fj.07-8283com

DO - 10.1096/fj.07-8283com

M3 - Article

C2 - 17855622

AN - SCOPUS:38949168061

VL - 22

SP - 561

EP - 568

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 2

ER -